These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 24766894)

  • 21. The Potential Role of Irisin in Vascular Function and Atherosclerosis: A Review.
    Byun K; Lee S
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of exercise in metabolic disorders are mediated by inhibition of mitochondrial-derived sterile inflammation.
    Peeri M; Amiri S
    Med Hypotheses; 2015 Dec; 85(6):707-9. PubMed ID: 26527493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases.
    Deuteraiou K; Kitas G; Garyfallos A; Dimitroulas T
    Rheumatol Int; 2018 Aug; 38(8):1345-1354. PubMed ID: 29869008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the inflammasome in cardiovascular diseases.
    Li X; Deroide N; Mallat Z
    J Mol Med (Berl); 2014 Apr; 92(4):307-19. PubMed ID: 24638861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts.
    Mamik MK; Power C
    Brain; 2017 Sep; 140(9):2273-2285. PubMed ID: 29050380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic Targets.
    Rovira-Llopis S; Apostolova N; Bañuls C; Muntané J; Rocha M; Victor VM
    Antioxid Redox Signal; 2018 Sep; 29(8):749-791. PubMed ID: 29256638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inflammasome and gout].
    Aringer M; Hedrich C; Tausche AK
    Z Rheumatol; 2016 Aug; 75(6):537-41. PubMed ID: 27418053
    [No Abstract]   [Full Text] [Related]  

  • 29. The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways.
    Jiang D; Chen S; Sun R; Zhang X; Wang D
    Cancer Lett; 2018 Apr; 419():8-19. PubMed ID: 29339210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome.
    Cumpelik A; Ankli B; Zecher D; Schifferli JA
    Ann Rheum Dis; 2016 Jun; 75(6):1236-45. PubMed ID: 26245757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Juniperus rigida Sieb. extract inhibits inflammatory responses via attenuation of TRIF-dependent signaling and inflammasome activation.
    Han JW; Shim DW; Shin WY; Kim MK; Shim EJ; Sun X; Koppula S; Kim TJ; Kang TB; Lee KH
    J Ethnopharmacol; 2016 Aug; 190():91-9. PubMed ID: 27260408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The concept of the inflammasome and its rheumatologic implications.
    So A; Busso N
    Joint Bone Spine; 2014 Oct; 81(5):398-402. PubMed ID: 24703401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammasomes: mechanism of action, role in disease, and therapeutics.
    Guo H; Callaway JB; Ting JP
    Nat Med; 2015 Jul; 21(7):677-87. PubMed ID: 26121197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammasome biology, molecular pathology and therapeutic implications.
    Awad F; Assrawi E; Louvrier C; Jumeau C; Georgin-Lavialle S; Grateau G; Amselem S; Giurgea I; Karabina SA
    Pharmacol Ther; 2018 Jul; 187():133-149. PubMed ID: 29466702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Immunological Basis in the Pathogenesis of Gout.
    Chen J; Wu M; Yang J; Wang J; Qiao Y; Li X
    Iran J Immunol; 2017 Jun; 14(2):90-98. PubMed ID: 28630380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammasomes and type 2 diabetes: An updated systematic review.
    Sepehri Z; Kiani Z; Afshari M; Kohan F; Dalvand A; Ghavami S
    Immunol Lett; 2017 Dec; 192():97-103. PubMed ID: 29079203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammasome activation in obesity-related inflammatory diseases and autoimmunity.
    Lukens JR; Dixit VD; Kanneganti TD
    Discov Med; 2011 Jul; 12(62):65-74. PubMed ID: 21794210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.
    Pellegrini C; Fornai M; Antonioli L; Blandizzi C; Calderone V
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphocyte roles in metabolic dysfunction: of men and mice.
    Ip BC; Hogan AE; Nikolajczyk BS
    Trends Endocrinol Metab; 2015 Feb; 26(2):91-100. PubMed ID: 25573740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of innate immunity in the pathogenesis of type 1 and type 2 diabetes.
    Lee MS
    J Korean Med Sci; 2014 Aug; 29(8):1038-41. PubMed ID: 25120311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.